Education
About Us
Working with TipRanks
Follow Us
David L. Lacey Insider Profile
4 Followers
David L. Lacey, Director at Unity Biotechnology, holds ― shares in Unity Biotechnology (Ticker: UNBX), holds 70.95K shares in Arcus Biosciences (Ticker: RCUS), holds ― shares in Atreca (Ticker: BCEL). Most recently, David L. Lacey ― shares of Unity Biotechnology on ― for an estimated value of ―.
David L. Lacey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David L. Lacey holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by David L. Lacey
David L. Lacey's Trading History
Unity Biotechnology
―
Director
―
―
Arcus Biosciences
Jun 12, 2025
Director
Uninformative Buy
―
$853.55K
Atreca
―
―
―
―
Nurix Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see David L. Lacey's performance on stock
You May Also Like
David L. Lacey insider profile FAQ
What is the percentage of profitable transactions made by David L. Lacey?
The percentage of profitable transactions made by David L. Lacey is ―.
What is the average return per transaction made by David L. Lacey?
The average return per transaction made by David L. Lacey is ―.
What stocks does David L. Lacey hold?
David L. Lacey holds: UNBX, RCUS, BCEL, NRIX stocks.
What was David L. Lacey’s latest transaction?
David L. Lacey latest transaction was an Uninformative Buy of ―.
What was David L. Lacey's most profitable transaction?
David L. Lacey’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is David L. Lacey's role in Unity Biotechnology?
David L. Lacey's role in Unity Biotechnology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.